European Urology

Article	Citations
Re: Immune Contexture Changes Following Blue Light Cystoscopy with Hexaminolevulinate in Bladder Cancer	1262
Manfred Wirth – A life devoted to urology in a time of change	1018
Editorial Board	710
The Platinum Hall of Fame	695
Honing Stratification and Treatment for High-risk Prostate Cancer	656
Re: Whole-genome Mutational Analysis for Tumor-informed Detection of Circulating Tumor DNA in Patients with Urothelial Carcinoma	510
Re: Carlotta Nedbal, Patrick Juliebø-Jones, Eamonn Rogers, et al. Improving Patient Information and Enhanced Consent in Urology: The Impact of Simulation and Multimedia Tools. A Systematic Literature	474
Editorial Board	436
Re: Johann S. de Bono, Meng He, Chen Shi, et al. Final Overall Survival and Molecular Data Associated with Clinical Outcomes in Patients Receiving Ipatasertib and Abiraterone in the Phase 3 IPATential	298
Reply to Felix Melchior, Andreas Pircher, and Isabel Heidegger’s Letter to the Editor re: Johann S. de Bono, Meng He, Chen Shi, et al. Final Overall Survival and Molecular Data Associated with Clinica	297
Re: Local Anaesthetic Transperineal Biopsy Versus Transrectal Prostate Biopsy in Prostate Cancer Detection (TRANSLATE): A Multicentre, Randomised, Controlled Trial	274
Re: Marcio Covas Moschovas, Shady Saikali, Marco Sandri, et al. Outcomes of Salvage Robotic-assisted Radical Prostatectomy: High-volume Multicentric Data from the European Association of Urology Robot	259
Reply to Jonas Hugosson. Population-based Screening for Prostate Cancer: Is It Time? Eur Urol. 2025;87:340–341	258
Development and validation of a new personalized algorithmic model for PSA analysis : PROSTia	227
18F-PSMA-11 as an Attractive 68Ga-PSMA-11 Alternative for Prostate Cancer Imaging	205
Re: The Prognostic Value of p53 and Ki-67 Expression Status in Penile Cancer: A Systematic Review and Meta-analysis	192
Re: Baris Turkbey, Henkjan Huisman, Andriy Fedorov, et al. Requirements for AI Development and Reporting for MRI Prostate Cancer Detection in Biopsy-Naïve Men: PI-RADS Steering Committee, Version 1.0.	180
Do women choose urology residency as much as men? Female urology resident representation in Spain in the last decade	178
Re: Adjuvant Atezolizumab Versus Placebo for Patients with Renal Cell Carcinoma at Increased Risk of Recurrence Following Resection (IMmotion010): A Multicentre, Randomised, Double-blind, Phase 3 Tria	178
P190 – The impact of radiographic disappearance of metastases as a new surrogate marker for therapy in patients with metastatic hormone-sensitive prostate cancer	168
P505 – The role of prostate-specific antigen after cryotherapy for primary localized prostate cancer	167
A0622 – Single-port nerve-sparing radical prostatectomy – initial learning curve of a high-volume multi-port surgeon	167
P410 – Perioperative and oncological outcomes of incomplete thermal ablations with or without immediate retreatment for patients with small renal masses	159
A0866 – A randomized, open-label, controlled clinical study to assess the digital health application INKA in the management of therapy refractory overactive bladder and mixed incontinence	156
A0519 – Efficacy and tolerability of androgen receptor targeted agents (ARTAs) in patients with metastatic castration-resistant prostate cancer (mCRPC) in different treatment sequences	148

A0492 – Adopting stone volume instead of maximum stone diameter: Worth it or an academic fantasy? Results from a worldwide survey	135
A0493 – Updated meta-analysis of VI-RADS score in image-guided assessment of muscle invasiveness in bladder cancer Pre-TURBT	135
P266 – From stones to strokes: How calcium kidney stones signal carotid atherosclerosis through oxidative stress	131
A0150 – Enrolment of racial and ethnic minority group patients in contemporary non-prostate cancer urological clinical trials: A systematic review	123
A0276 – OPUS program: Organized prostate cancer screening in Mexico	123
A0634 – Evaluation of Salvage High Intensity Focused Ultrasound (S-HIFU) and hemi-S-HIFU for radiorecurrent prostate cancer	115
P393 – Identification, validation and pathway enrichment analysis of differentially expressed genes and miRNAs as diagnostic biomarkers in clear cell renal cell carcinoma	112
A0228 – A randomized controlled trial comparison of stent-related symptoms between anti-reflux stents and standard double-J stents in school-age children	108
A0611 – Prediction of prostate cancer biochemical recurrence by a specific collagen-related proteo-transcriptomics signature	103
V115 – Management of pelvic vessels injury during robotic pelvic urooncology procedures	101
GC6 – Micro-ultrasound-guided versus MRI-guided biopsy for prostate cancer diagnosis (OPTIMUM trial)	100
A0872 – Real-world experience and long-term survival of high-risk non-muscle invasive bladder cancer treated with BCG: 5-year outcomes from a large UK tertiary referral centre	99
A0607 – What is the optimal BCR-free survival cut-off predicting favourable long-term outcomes? A multicenter retrospective EMPaCT study	99
A0321 – Definition of risk categories for urethral stricture recurrence after free graft bulbar urethroplasty using classification and regression tree analysis	97
A0796 – Cost-effectiveness analysis of treatments for BCG-unresponsive high-risk NMIBC	95
A0347 – The genotype-phenotype association in von Hippel-Lindau (VHL) disease with the codon 167 missense mutations: A large retrospective study/a population-based study	94
A0248 – Natural and assisted conceptions in young men treated for hematological cancer who stored their semen for fertility preservation	91
A0546 – The diagnostic potential of the penile cavernous density measurement by ultrasound	90
P369 – Predictors of intraoperative conversion from robotic to open radical cystectomy and effects on patients survival	90
A0484 – Endourology clinic: Artificial intelligence vs. natural intelligence	89
P082 – Age disparity in couples seeking first medical help for infertility has changed over the last twenty years: A sociological study	88
A0100 – Day care PCNL: Who Qualifies? Introducing the day-care PCNL checklist	87
A0677 – Bladder EpiCheck triggered photodynamic diagnosis biopsies detect high grade recurrences missed by white light cystoscopy	84
A0459 – Is there an oncological benefit of extended pelvic lymph node dissection at the time of radical prostatectomy in PSMA-PET node negative prostate cancer patients? Results from a multi-instituti	84
P033 – Is the routine histological analysis of paediatric foreskin specimens following a circumcision justified?	84
A0486 – Comparison of 1-mm vs. 0.5-mm thick reconstructed images to evaluate residual stone fragments and dust particles: An evaluation using porcine kidneys	83
P547 – Genomic insights into intraductal carcinoma of the prostate from the Genomic Umbrella Neoadjuvant Study (GUNS) in high-risk localized prostate cancer	83
P213 – The influence of STAT1 butyrylation in the prostate transition zone on benign prostatic hyperplasia via the NOTCH1/ATF3 pathway	83
P639 – Site-specific differences of eligibility for adjuvant immunotherapy among urothelial carcinoma patients treated with radical surgery: Results of a multicenter cohort study	83
P203 – Systemic immune inflammation and stress urinary incontinence	83
P526 – Single port versus multiport robotic nephroureterectomy with bladder cuff exicision: Comparative study for initial cases	78
A0759 – Vecto® prostate biopsy: 4-year outcomes of novel MRI-US fusion, transperineal prostate biopsies under local anaesthesia, utilising electromagnetic needle tracking	78
P219 – The quality of life of pregnant patients after active and delayed endourological treatment of urolithiasis	78
P225 – Effect of preoperative urine culture timing on postoperative outcomes of retrograde intrarenal surgery: Preliminary results of the RIRSearch study	74
Robotic Bladder Auto-transplantation in a Heart-beating Brain-dead Human Research Donor	73
Editorial Board	71
Re: Duration of Androgen Deprivation Therapy with Postoperative Radiotherapy for Prostate Cancer: A Comparison of Long-course Versus Short-course Androgen Deprivation Therapy in the RADICALS-HD Random	71
Acknowledgement to Reviewers	71
Re: Unplanned Conversion from Partial to Radical Nephrectomy: An Analysis of Incidence, Etiology, and Risk Factors	70
Qualitative assessment of patient-reported outcomes in urinary and sexual function in patient after perineal urethrostomy	69
Surgical and oncologic outcomes of surgery in early metastatic seminoma: Multi-institutional retrospective study	68
MRI/US fusion targeted prostate biopsies koelis®: Impact of operator experience on clinicaly significant prostate cancer detection	67
Prenatal exposure to SSRI antidepressants and time of neonatal first void - A case control study	67
Development of an individual postoperative prediction model for kidney cancer recurrence using machine learning (UroCCR study 120)	67
Radiomics-based prognostic model guided by artificial intelligence to predict lymph node invasion and biochemical recurrence in patients with high-grade prostate cancer	66
De-escalation of monitoring for prostate cancer active surveillance: Results of the GAP3 consortium	66
Mechanism of cystine stone growth revealed by ultrastructural observation using scanning electron microscopy	66
Immunoprophyaxis with MV-140 is effective in the prevention of urinary tract infections – results of a prospective study	66
LEST: Anatomical ablative ejaculation sparing surgery for BPH	66
What are the optimal laser settings for stone dusting using the popcorn technique	65

Re: Loren K. Mell, Stephanie L. Pugh, Christopher U. Jones, et al. Effects of Androgen Deprivation Therapy on Prostate Cancer Outcomes According to Competing Event Risk: Secondary Analysis of a Phase	64
Construction of cuproptosis signature based on bioinformatics and experimental validation in clear cell renal cell carcinoma	64
Prostatectomy vs. radiotherapy for regional node positive prostate cancer	64
Erogenous and aversive sensation throughout the vulva, vagina, and breasts in cis-gender women: Anatomic heat-map to assess effect of treatment on erogenous sensation	63
Photodynamic diagnosis (PDD) directed biopsies vs white light bladder mapping in patients with positive cytology and negative preoperative workup: An international multicenter retrospective study. On	63
Assessing the potential of cystatin 4 as a blood biomarker for prostate cancer diagnosis and prognosis: A prospective single-center study	62
Is testosterone replacement therapy effective and safe even for eugonadal men with symptom of late onset hypogonadism?	62
Re-treatment for Lower Urinary Tract Symptoms (LUTS) after water vapor thermal therapy	61
More micrometastases, more recurrence? Assessing the role of quantitative rtPCR of PSA from lymph nodes post-prostatectomy in predicting biochemical recurrence - an experimental study	60
Reclassification of small renal masses according to the EAU Guidelines newly-proposed TNM classification for suspected renal cell carcinoma: Implications for decision-making	58
Quantitative MRI parameters providing the novel value in discriminating muscle-invasive bladder cancer	57
Incidental prostate cancer in patients treated for benign prostatic hyperplasia: Analysis from a contemporary national dataset	57
Putting Precision Medicine in Prostate Cancer into Practice: Are We There Yet?	56
Prognostic value of circulating tumor cells and cell-free DNA in upper tract urothelial carcinoma	56
Lawton instrumental activities of daily living scale identifies patients at high-risk of adverse outcomes after kidney surgery for renal cancer: A prospective clinical study	56
Robot-assisted radical prostatectomy for prostate cancer: 18-year oncological outcomes from a Belgian high-volume center	55
Which men with cN1 prostate cancer at PSMA PET/CT represent the ideal candidate for radical prostatectomy? Development of a novel risk stratification tool for individualized approaches based on a larg	55
100 years of history-making urology – the Portuguese urology association	54
Outcomes of urethroplasty (UP), 10 years after surgery	54
Transcriptomic analysis of the lncRNA-miRNA-mRNA axis network in aldosterone-producing adenoma	54
Epidemiological outcomes in immunocompromised vs. immunocompetent prostate cancer patients: A systematic review, meta-analysis and meta-regression	54
A comprehensive in vitro assessment of thulium fiber laser in soft tissues and stones	53
Clinicopathological correlate of urine 8-hydroxydeoxyguanosine levels in patients with prostate biopsy	52
Fosfomycin for antibiotic prophylaxis in men undergoing a transrectal prostate biopsy: A systematic review and meta-analysis	52
Minimally invasive cytoreductive nephrectomy for metastatic renal cell carcinoma in the immunotherapy era: Results from the REMARC-IO database	52
Contents	52
Cumulative thulium fiber laser energy and stone-free rates: Outcomes from the team of worldwide endourological researchers (TOWER) thulium fiber laser registry	51
Bladder EpiCheck methylation test predicts short- and long-term HG events in bladder cancer patients treated with bacillus Calmette-Guérin	51
Rezūm water vapour therapy (Rezūm): Is it safe to continue antiplatelet or anticoagulation medication?	51
The development of a hollow three-dimensional kidney spheroid model for the study of calcium-containing crystal formation	50
Protein-based molecular subtypes associate with clinical-pathological characteristics in a multi-institutional cohort of upper tract urothelial carcinomas	50
Propensity-score matched survival analysis of octogenarians with muscle-invasive bladder cancer: Chemoradiation compared to radical cystectomy	49
Re: Bhavan P. Rai, José Luis Dominguez Escrig, Luís Vale, et al. Systematic Review of the Incidence of and Risk Factors for Urothelial Cancers and Renal Cell Carcinoma Among Patients with Haematuria.	48
Contents	48
Improved survival in contemporary actively treated community-based metastatic clear-cell renal cell carcinoma patients	48
Patient-derived organoids represent intra- and interindividual heterogeneity in castration-resistant prostate cancer	46
Prostate cancer prevention clinic for men with risk of familial prostate cancer (profam-risk)	46
Sutureless robot assisted partial nephrectomy: Feasibility and surgical technique (UroCCR n°158)	45
Single-port vs. multi-port robot-assisted partial nephrectomy: A single center propensity-score matched analysis	45
Efficacy and safety of low-dose tadalafil compared to tolterodine and placebo in females with overactive bladder symptoms. A prospective double blind controlled study	45
Efficacy and safety of darolutamide in combination with androgen-deprivation therapy and docetaxel in European patients from the phase 3 ARASENS trial	45
The Platinum Hall of Fame	45
Impact of radical prostatectomy on pelvic floor muscles: An electromyography and perineometric assessment	43
Use cluster analysis to develop an accurate and practical diagnostic method for detrusor underactivity in female patient without bladder outlet obstruction	43
AI-based classification and segmentation method for bladder cancer from cystoscopic image: Preliminary study	42
Retzius-sparing robot-assisted radical prostatectomy for large prostate volumes: Surgical and functional outcomes	42
Multi-centre study comparing outcomes of RIRS using traditional suction ureteral access sheath (SUAS) and flexible-navigable suction UAS (FANS)	42
Strengths and weaknesses of using Optum Clinformatics Data Mart to study in-vitro fertilization	41
Functional and endoscopic results up to two years after Aquablation for BPH-related LUTS: A single centre first clinical experience	41
Non-infectious adverse events of transperineal prostate biopsies performed under local anesthesia in an outpatient setting – results from the NORAPP study – a randomized clinical trial	41
Radiomics model to predict teratoma in metastatic non-seminomatous testicular germ cell tumors	41
Minimally invasive adrenalectomy for the treatment of malignant adrenal metastasis: Results from two high volume centers	41
First-in-human experience with the LithoVueTM elite single use ureteroscope: Can intrarenal pressure be manipulated?	41
Salvage focal ablation versus radical prostatectomy for localized radiorecurrent prostate cancer: A propensity-score matched comparison	40
Re: Matthew S. Ernst, Vishal Navani, J. Connor Wells, et al. Outcomes for International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Groups in Contemporary First-line Combination The	40
Association between age and efficacy of first-line immunotherapy-based combination therapies for mRCC: A meta-analysis	40
Persistently elevated urinary inflammatory biomarkers may predict recurrence of recurrent urinary tract infection in women	40
Comparison of two different approaches in the management of infants with primaryobstructive megaureters and their long-term outcomes	40
The international bladder cancer group intermediate-risk non-muscle invasive bladder cancer (IBCG IR-NMIBC) scoring system predicts the need for intervention for patients on active surveillance	39
The next generation trial: Assessing 18F-PSMA-1007 positron emission tomography and magnetic resonance imaging in the primary staging of prostate cancer patients	39
What is new at the deepest point of human civilization for andrologic point of view?	38
Impact of systemic therapy in clinical T1 small-cell neuroendocrine carcinoma of the bladder	38
Comparing PSA screening patterns and their role as predictor of prostate cancer incidence and mortality: A system wide analysis of a contemporary North American cohort	37
Replacing ReTUR with Cystoscopy in High-Grade T1 NMIBC patients: Confirmatory results from the HuNIRe Trial	37
Efficacy of sacral nerve modulation in the treatment of neurogenic overactive bladder in patients with multiple sclerosis	37
Epidermal growth factor-like domain 7 inhibit immune response in metastatic castration resistant prostate cancer by de-activation of endothelial intercellular adhesion molecule-1	36
P0525 Patient-reported use and effect of sexual aids for erectile dysfunction within 8 years after radical prostatectomy	36
Incremental value of machine learning-based radiomics for preoperative discrimination between malignant and benign small renal masses	36
P1010 The Southern Denmark ureteral stricture center: Establishing a cross-institutional collaboration	36
A0120 Single-center experience with 3049 pediatric robotic urological surgeries	35
P0134 DEPECA-2 (DEfeating PEnile CAncer 2) – robot-assisted vs. open inguinal lymphadenectomy for penile cancer – a prospective randomized trial with a supporting translational program	34
P0731 Influence of intraoperative tranexamic acid on bleeding outcomes in patients receiving antithrombotic therapy undergoing endoscopic enucleation of the prostate: A multicenter prospective study b	34
P0062 Autologous live-cultured buccal epithelial cells for bulbar urethral strictures: 24-months follow-up results	34
A0418 Does one-dimensional stone measurement support clinical decision-making? A retrospective cohort analysis of surface area and stone volume	34
P0132 Penile vibratory stimulation in the prevention of sexual dysfunction and urinary incontinence after radical prostatectomy (ProVibrate)	34
P0346 Response-adapted neoadjuvant intensification with abiraterone and LHRH agonist ± docetaxel before radical prostatectomy in high-risk localized prostate cancer: A prospective cohort study emulati	33
A0427 AI laser-integrated vision system for lithotripsy: Real-time stone composition detection	33
A0044 Comprehensive pathological analysis of 1,369 renal cell carcinoma patients reveals novel biomarkers and establishes a predictive model for clinical outcomes	33
P0185 Beyond testosterone: The role of dehydroepiandrosterone sulfate and estradiol in erectile dysfunction in men without hypoandrogenism	32
A0296 Real-world incidence and clinical impact of grade 3–4 adverse events in patients with metastatic renal cell carcinoma treated with first-line immune combinations: ARON-1 study	32

P0473 Development and internal validation of machine-learning models to predict adverse pathological features in upper tract urothelial carcinoma using data from the ROBUUST 3.0 collaborative	32
A0643 A study protocol to evaluate the accuracy metrics of en-face fluorescence confocal microscopy (LaserSAFE) for margin analysis during radical prostatectomy	32
A0563 The impact of the peritoneal flap on lymphocele formation following robotic assisted radical prostatectomy with pelvic lymph node dissection: A systematic review and meta-analysis	31
A0773 Synergistic impact of LRRC15⁺ stroma and CD163⁺ macrophage infiltration on metastasis in upper tract urothelial carcinoma	31
A0383 Entinostat overcomes cisplatin resistance in bladder cancer by promoting H3K18lamediated DHRS2 expression to suppress the AKR1C3-androgen axis	31
P0389 Quantifying surgical experience and performance improvement in robot-assisted partial nephrectomy using intraoperative analytics	31
A0729 Construction of an integrated proteomic atlas for penile squamous cell carcinoma	31
A0525 Prostate cancer stage vs. leading causes of death	31
A0629 10-year urothelial fellowship in Robotic-assisted Radical Cystectomy and Intracorporeal Ileal Conduit (RARC/ICIC) urinary diversion: Trends in surgical practice, perioperative outcomes, and pred	30
P0144 Clinical outcomes for Caval Thrombus involved Renal Cancer (IR1 – CAVALThromb): a prospective, multicentre, international registry	30
A0185 Three-dimensional image-guided robot-assisted partial nephrectomy for tumors in horseshoe kidneys: A European multicentre case series (YAU RCC – UroCCR)	30
A0106 Influence of ureteral access sheaths and irrigation techniques on intrarenal pressure in a porcine model	30
A0505 Sacral neuromodulation device explantation: A 12-year experience from a highvolume tertiary center	30
P0270 Single-port retroperitoneal lower anterior robotic partial nephrectomy: Impact of surgical access on intraoperative anesthesiologic parameters	30
P0986 Risk factors and microbial etiology of healthcare-associated urinary tract infections in neurological patients: Analysis of 1100 cases	30
P0635 Teaching Robot-Assisted Radical Cystectomy (RARC) is safe - results from the prospective Swiss Society of Urology database	29
P0373 Predicting gene expression and patient outcomes in muscle-invasive bladder cancer using integrated foundation model ensemble	29
V035 Dorso-lateral preputial graft augmentation in panurethral stricture by penile invagination	29
A0748 Refining PSA doubling time thresholds to predict metastases after biochemical recurrence in prostate cancer patients treated with radical prostatectomy	29
A0654 The COBRA study: Chemoablation or bladder resection with adjuvant chemotherapy in recurrent non-muscle invasive bladder cancer	29
P0209 Predictors of disease recurrence and progression of non-muscle-invasive bladder cancer following en bloc resection of bladder tumour: Insights from the global ERBT registry	29
A0767 Anatomical refinement matters: Ureteropelvic junction location confers survival benefit for patients with upper tract urothelial carcinoma after radical nephroureterectomy	29
A0859 89Zirconium-labelled girentuximab PET in patients with urothelial cancer (ZiPUP) - a phase 1 study of a novel staging modality for urothelial carcinoma	28
V020 Robotic ileal conduit reconstruction: A 10-step guide	28
A0716 Adverse events and device malfunctions in da Vinci robotic surgery: Analysis of MAUDE data from the recent ten years	28
A0200 “To circ or not to circ” – that is the question for patients with posterior urethral valves	28
P0875 Cost-effectiveness analysis of new perioperative treatment regimens for muscleinvasive bladder cancer	28
A0839 MRI-targeted biopsy with index lesion ipsilateral or bilateral systematic biopsy in prostate cancer: A multicenter, paired, noninferiority, observational trial	28
V024 Upper urinary tract reconstruction for the treatment of ureteral stricture in a duplex collecting system: Our experience	27
A0040 A step forward in RCC staging: External validation of the EAU-proposed M staging	27
P0832 The prognostic value of PTEN expression in localized prostate cancer	27
A0626 Naloxegol does not improve gastrointestinal recovery after radical cystectomy within contemporary ERAS protocols: A multicenter prospective cohort study	27
P0037 Bone scan index as a better prognostic imaging biomarker for disease progression among patients with CHAARTED high-volume metastatic castration sensitive prostate cancer	27
A0627 Structured prehabilitation reduces ICU admission and transfusion rates after radical cystectomy – interim analysis of the PRACTICE randomized trial (NCT06806059)	27
Molecular Urothelial Tumor Cell Subtypes Remain Stable During Metastatic Evolution	26
Prostate-Specific Antigen Screening in Transgender Patients	26
A0182 Predicting surgical outcomes in single-port robot-assisted partial nephrectomy: External validation and comparative analysis of PADUA, RENAL, and SPARE scores	26
Infigratinib Versus Placebo for Patients with High-risk Resected Urothelial Cancer Bearing an FGFR3 Genomic Alteration: Results from the PROOF302 Phase 3 Trial	26
Re: W. Marston Linehan, Cathy Anne Pinto, Yanfang Liu, et al. Longitudinal Evaluation of Clear-cell Renal Cell Carcinoma in von Hippel-Lindau Disease. Eur Urol 2025;88:56–63	26
Surgical outcomes of robot-assisted radical prostatectomy with the novel HUGO™ robotic system: Initial 100 cases performed at a tertiary referral robotic center	26
A prospective paired comparison trial on mirabegron and anticholinergics in patients with low bladder compliance	25
Reply to Nour Khalil, Guiseppe Maiolino, and Eric Barret’s Letter to the Editor re: Rui M. Bernardino, Theodorus van der Kwast, Neil E. Fleshner. Intraductal Carcinoma and Cribriform Pattern in Prosta	25
Rare Germline Variants Are Associated with Rapid Biochemical Recurrence After Radical Prostate Cancer Treatment: A Pan Prostate Cancer Group Study	25
Prognostic Value of Interim PSMA-PET Total Tumor Volume for Overall Survival Within ENZA-p, A Randomized Phase 2 Trial of Enzalutamide Versus Enzalutamide Plus [177Lu] Lu-PSMA-617 (ANZUP1901)	25
Re: Nicolas Demogeot, Paul Sargos, Julia Salleron, et al. Short-term Androgen Deprivation Therapy and High-dose Radiotherapy in Intermediate- and High-risk Localized Prostate Cancer: Results from the	25
Assessing Long-term Treatment Benefits Using Complementary Statistical Approaches: An In Silico Analysis of the Phase III Keynote-045 and Checkmate-214 Immune Checkpoint Inhibitor Trials	25
Pembrolizumab Retreatment in Patients with Advanced or Metastatic Urothelial Carcinoma Who Responded to First-course Pembrolizumab-based Therapy	25
Short-term morbidity and long-term functional outcomes of the T-plasty for salvage reconstruction of recalcitrant bladder neck stenosis	25
Re: Philip Cornford, Roderick C.N. van den Bergh, Erik Briers, et al. EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer—2024 Update. Part I: Screening, Diagnosis, and Local Treatment with Cu	25
More Than Words: Defining Adjuvant, Consolidative, and Salvage Treatment after Radical Prostatectomy	25
Pembrolizumab in Combination With Gemcitabine and Concurrent Hypofractionated Radiation Therapy as Bladder-sparing Treatment for Muscle-invasive Urothelial Cancer of the Bladder: A Multicenter Phase 2	25
Aberrant Splice Variants: A Novel Characterization of Clear Cell Renal Cell Carcinoma	25
Tumors of the Urinary System and Male Genital Organs: 2022 World Health Organization Classification and Multidisciplinarity	24
A0078 – IP8-FLUORESCE: A prospective paired-cohort study evaluating fluorescence confocal microscopy for rapid evaluation of surgical margins in radical prostatectomy	24
Cost-effectiveness Analysis of Treatments for Bacillus Calmette-Guérin–unresponsive Carcinoma in Situ of the Bladder	24
Re: Christof Vulsteke, Nabil Adra, Pongwut Danchaivijitr, et al. Perioperative Enfortumab Vedotin and Pembrolizumab in Bladder Cancer. N Engl J Med 2026;394:1257–1269	24
V048 StoneMetricAI by Medannot - one click, real volume: Smarter stone assessment starts here	24
Re: Global Burden of Bacterial Antimicrobial Resistance in 2019: A Systematic Analysis	23
Reply to Youyi Lu, Lin Wang, and Jitao Wu’s Letter to the Editor re: Guohua Zeng, Kehua Jiang, Shusheng Liu, et al. Flexible Ureteroscopy with a Flexible and Navigable Suction Ureteral Access Sheath V	23
Prostate Cancer Active Surveillance Without Biopsy? Not Quite Yet, but Watch This Space	23
Re: Nicolaus F. Debatin, Elena Bady, Tim Mandelkow, et al. Prognostic Impact and Spatial Interplay of Immune Cells in Urothelial Cancer. Eur Urol. 2024;86:42–51	23
European Association of Urology-American Society of Clinical Oncology Collaborative Guideline on Penile Cancer: 2023 Update	23
Re: Massimiliano Creta, Giorgio I. Russo, Naeem Bhojani, et al. Bladder Outlet Obstruction Relief and Symptom Improvement Following Medical and Surgical Therapies for Lower Urinary Tract Symptoms Sugg	23
Contents	23
Congress Calendar	22
Refining the Tissue Source for Biomarker-based Approaches in Renal Cell Carcinoma	22
A Novel Heterologous Prime-boost Strategy Using RUTI Vaccine to Improve the Bacillus Calmette-Guérin Response in Non–muscle-invasive Bladder Cancer Patients: Phase 1 RUTIVAC-1 Trial	22
IP8-FLUORESCE: A Prospective Paired Cohort Study Evaluating the Diagnostic Accuracy of Fluorescence Confocal Microscopy for Real-time Assessment of Surgical Margins in Radical Prostatectomy	22
Editorial Board	22
Re: Male-partner Treatment to Prevent Recurrence of Bacterial Vaginosis	22
Reply to Marco Bandini and Francesco Montorsi’s Letter to the Editor re: Matthew Lee, Michael Lesgart, Connor McPartland, et al. Robotic Transvesical Bladder Neck Reconstruction: A Novel Approach to M	22
Re: A New Technique for the Treatment of Ureteric Stricture After Kidney Transplantation	22
Re: A Randomized Trial of PHOTOdynamic Surgery in Non–muscle-invasive Bladder Cancer	21
P0604 Resveratrol ameliorates bladder outlet obstruction–induced bladder dysfunction in rats via modulation of TGF-β–associated pathways: Integrative transcriptomic and proteomic evidence	21
Reply to Salvatore Cozzi and Thomas Zilli’s, and Alexander Ho and Sean Sachdev’s Letters to the Editor re: Markus Graefen, Fabian Falkenbach, Tobias Maurer, et al. Best Systemic Therapy With or Withou	21
P0801 Predictors of recurrence after bulbar urethroplasty following BPH surgery: A multicenter retrospective study	21
A0504 – A non-coding RNA based classifier for favorable outcomes in clinically organ confined bladder cancer patients undergoing radical cystectomy surgery	21
P0910 Targeting lactate production or key lactylated proteins sensitizes bladder cancer to cisplatin therapy	21
P0084 Pre-diagnostic plasma proteomics profile uncovers new biomarkers and mechanistic insights for incident kidney cancer	20
P0146 Epidemiology and treatment patterns of metastatic hormone-sensitive prostate cancer in France (EPICAP): Insights from a retrospective claims database study	20
P0626 Significant asymmetry in positive surgical margins during robot-assisted radical prostatectomy: A higher incidence on the left side	20
P0625 Early versus delayed specimen inking: the impact on margin status in Retziussparing robot-assisted radical prostatectomy - a comparative analysis	20
A0630 Risk of lymph-node invasion after radical cystectomy according to histological subtypes: Results from a large multi-institutional cohort	20
P0104 Post-massage PSA kinetics predict therapeutic response in chronic prostatitis/chronic pelvic pain syndrome	19
A0535 Predictors of surgical retreatment following Rezūm water vapor therapy: A multicenter real-world analysis	19
P0271 Robotic fascia lata sacrocolpopexy: A single center study	19
V053 Modified technique of robot assisted laparoscopic repair of vesicovaginal fistula	19
A0020 Ultrasound-based predictors of polyacrylamide hydrogel injection success in stress urinary incontinence: Longitudinal study by a single experienced surgeon	19
A0184 Optimization of postoperative care for nephrectomy patients using the UroConnect telemonitoring tool (UroCCR n°129)	19
P0361 Preoperative surgical planning for high-risk prostate cancer: Maximising continence while maintaining oncological safety of nerve-sparing robotic prostatectomy	19
A0666 Fluid dynamics of gravel removal in flexible ureteroscopic lithotripsy with FANS	19
P0295 Targeting ferroptosis and macrophage-to-myofibroblast transition in renal fibrosis induced by urinary obstruction: Deciphering the multitarget therapeutic effects of a modified carbon dots	19
A0649 Trial in progress: Evaluation of urinary minimal residual disease and outcomes in high-risk non-muscle invasive bladder cancer surveilled with blue light compared to white light cystoscopy	19
V025 Robotic assisted laparoscopic management of upper ureteric strictures	18
A0837 Diagnostic value of contralateral systematic biopsy and MRI local staging (rT) in predicting bilateral prostate cancer in radical prostatectomy specimens	18